OBJECTIVE: Fine particulate matter <2.5 microm (PM(2.5)) has been implicated in vasoconstriction and potentiation of hypertension in humans. We investigated the effects of short-term exposure to PM(2.5) in the angiotensin II (AII) infusion model. METHODS AND RESULTS: Sprague-Dawley rats were exposed to PM(2.5) or filtered air (FA) for 10 weeks. At week 9, minipumps containing AII were implanted and the responses studied over a week. Mean concentration of PM(2.5) inside the chamber was 79.1+/-7.4 microg/m(3). After AII infusion, mean arterial pressure was significantly higher in PM(2.5)-AII versus FA-AII group. Aortic vasoconstriction to phenylephrine was potentiated with exaggerated relaxation to the Rho-kinase (ROCK) inhibitor Y-27632 and increase in ROCK-1 mRNA levels in the PM(2.5)-AII group. Superoxide (O(2).(-)) production in aorta was increased in the PM(2.5)-AII compared to the FA group, inhibitable by apocynin and L-NAME with coordinate upregulation of NAD(P)H oxidase subunits p22(phox) and p47(phox) and depletion of tetrahydrobiopterin. In vitro exposure to ultrafine particles (UFP) and PM(2.5) was associated with an increase in ROCK activity, phosphorylation of myosin light chain, and myosin phosphatase target subunit (MYPT1). Pretreatment with the nonspecific antioxidant N-acetylcysteine and the Rho kinase inhibitors (Fasudil and Y-27632) prevented MLC and MYPT-1 phosphorylation by UFP suggesting a O(2)(.-)-mediated mechanism for PM(2.5) and UFP effects. CONCLUSIONS: Short-term air pollution exaggerates hypertension through O(2)(.-)-mediated upregulation of the Rho/ROCK pathway.
OBJECTIVE: Fine particulate matter <2.5 microm (PM(2.5)) has been implicated in vasoconstriction and potentiation of hypertension in humans. We investigated the effects of short-term exposure to PM(2.5) in the angiotensin II (AII) infusion model. METHODS AND RESULTS:Sprague-Dawley rats were exposed to PM(2.5) or filtered air (FA) for 10 weeks. At week 9, minipumps containing AII were implanted and the responses studied over a week. Mean concentration of PM(2.5) inside the chamber was 79.1+/-7.4 microg/m(3). After AII infusion, mean arterial pressure was significantly higher in PM(2.5)-AII versus FA-AII group. Aortic vasoconstriction to phenylephrine was potentiated with exaggerated relaxation to the Rho-kinase (ROCK) inhibitor Y-27632 and increase in ROCK-1 mRNA levels in the PM(2.5)-AII group. Superoxide (O(2).(-)) production in aorta was increased in the PM(2.5)-AII compared to the FA group, inhibitable by apocynin and L-NAME with coordinate upregulation of NAD(P)H oxidase subunits p22(phox) and p47(phox) and depletion of tetrahydrobiopterin. In vitro exposure to ultrafine particles (UFP) and PM(2.5) was associated with an increase in ROCK activity, phosphorylation of myosin light chain, and myosin phosphatase target subunit (MYPT1). Pretreatment with the nonspecific antioxidant N-acetylcysteine and the Rho kinase inhibitors (Fasudil and Y-27632) prevented MLC and MYPT-1 phosphorylation by UFP suggesting a O(2)(.-)-mediated mechanism for PM(2.5) and UFP effects. CONCLUSIONS: Short-term air pollution exaggerates hypertension through O(2)(.-)-mediated upregulation of the Rho/ROCK pathway.
Authors: A Nemmar; P H M Hoet; B Vanquickenborne; D Dinsdale; M Thomeer; M F Hoylaerts; H Vanbilloen; L Mortelmans; B Nemery Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Kristin A Miller; David S Siscovick; Lianne Sheppard; Kristen Shepherd; Jeffrey H Sullivan; Garnet L Anderson; Joel D Kaufman Journal: N Engl J Med Date: 2007-02-01 Impact factor: 91.245
Authors: Ulf Landmesser; Sergey Dikalov; S Russ Price; Louise McCann; Tohru Fukai; Steven M Holland; William E Mitch; David G Harrison Journal: J Clin Invest Date: 2003-04 Impact factor: 14.808
Authors: Loren E Wold; Zhekang Ying; Kirk R Hutchinson; Markus Velten; Matthew W Gorr; Christina Velten; Dane J Youtz; Aixia Wang; Pamela A Lucchesi; Qinghua Sun; Sanjay Rajagopalan Journal: Circ Heart Fail Date: 2012-06-01 Impact factor: 8.790
Authors: Ralph J Delfino; Thomas Tjoa; Daniel L Gillen; Norbert Staimer; Andrea Polidori; Mohammad Arhami; Larry Jamner; Constantinos Sioutas; John Longhurst Journal: Epidemiology Date: 2010-05 Impact factor: 4.822
Authors: Nicholas L Mills; Ken Donaldson; Paddy W Hadoke; Nicholas A Boon; William MacNee; Flemming R Cassee; Thomas Sandström; Anders Blomberg; David E Newby Journal: Nat Clin Pract Cardiovasc Med Date: 2008-11-25
Authors: Wei Huang; Lu Wang; Jianping Li; Mochuan Liu; Hongbing Xu; Shengcong Liu; Jie Chen; Yi Zhang; Masako Morishita; Robert L Bard; Jack R Harkema; Sanjay Rajagopalan; Robert D Brook Journal: Am J Hypertens Date: 2018-04-13 Impact factor: 2.689
Authors: Elissa Wilker; Murray A Mittleman; Augusto A Litonjua; Audrey Poon; Andrea Baccarelli; Helen Suh; Robert O Wright; David Sparrow; Pantel Vokonas; Joel Schwartz Journal: Environ Health Perspect Date: 2009-02-03 Impact factor: 9.031